SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-17-218406
Filing Date
2017-06-29
Accepted
2017-06-29 16:38:01
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 d392617d424b3.htm 424B3 96875
2 GRAPHIC g392617g0509130455010.jpg GRAPHIC 6487
3 GRAPHIC g392617g0509134414442.jpg GRAPHIC 6487
4 GRAPHIC g392617logo.jpg GRAPHIC 3277
  Complete submission text file 0001193125-17-218406.txt   120890
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-217889 | Film No.: 17938778
SIC: 2834 Pharmaceutical Preparations